VC  Breakout Labs

     Office Locations:

Thiel Foundation
One Letterman Drive, Bldg. C, Suite 400
San Francisco, CA 94129



  • Early
  • Seed



  • Life Sciences & Healthcare



    Breakout Labs is the Thiel Foundation's newest program that looks to invest in early stage science and technology companies. Projects should fall within the categories of revolutionary platforms (molecular design, instrumentation, assays, or therapeutic interventions), proof of concept for next-stage funding, or research on topics outside the scope of federal funding. Funding agreements are made on a rolling basis and typically range from $50,000 to $350,000 in the form of grants. Breakout Labs does not fund clinical trials or programs that target specific diseases or conditions as an end goal. Through the Breakout Labs grant agreement, funded companies retain IP that arises from the project while committing a capped royalty stream and a small percentage of equity in their company to the firm.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Ajay Royan Executive Committee Member
    Grace Eckert Program Coordinator
    Hemai Parthasarathy Scientific Director
    James O'Neill Executive Committee Member
    Leonore Reiser Program Manager


    Portfolio companies include:

        web link

      Arigos Biomedical


      Bell Biosystems
        web link

        web link

        web link

      General Genomics

        web link

        web link

      Longevity Biotech
        web link

      Modern Meadow
        web link

      Pareto Biotechnologies

      Positron Dynamics
        web link

      Siva Therapeutics
        web link

        web link

      Stealth Biosciences
        web link


    Recent News: